US Patent Issued to Regeneron Pharmaceuticals on Aug. 11 for "Non-human animals comprising a humanized ACE2 locus" (New York Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,702,122, issued on Aug. 11, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).

"Non-human animals comprising a humanized ACE2 locus" was invented by Susannah Brydges (Scarsdale, N.Y.), Christos Kyratsous (Irvington, N.Y.) and Alina Baum (Pleasantville, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Non-human animal cells and non-human animals comprising a humanized ACE2 locus and methods of using such non-human animal cells and non-human animals are provided. Non-human animal cells or non-human animals comprising a humanized ACE2 locus express a human ACE2 protein or a chimeric ACE2 protein, fragments of which are from human ACE2. Me...